Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Experimental Gerontology, Elsevier BV, Vol. 48, No. 7 ( 2013-07), p. 698-
    Type of Medium: Online Resource
    ISSN: 0531-5565
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2013
    detail.hit.zdb_id: 2005397-6
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Ovid Technologies (Wolters Kluwer Health) ; 2022
    In:  Circulation Research Vol. 131, No. Suppl_1 ( 2022-08-05)
    In: Circulation Research, Ovid Technologies (Wolters Kluwer Health), Vol. 131, No. Suppl_1 ( 2022-08-05)
    Abstract: Although they were originally misclassified as lncRNAs due to oversights in genome annotation methods, microproteins—proteins with open reading frames (ORFs) of 150 amino acids or less—execute critical roles in heart and skeletal muscle. We have identified a novel microprotein, MPTM1, that is enriched in cardiac and skeletal muscle tissues. The MPTM1 amino acid sequence is strongly conserved across multiple species, which indicates that it is a functional microprotein that has been maintained in response to evolutionary pressure. Genome-wide association studies (GWAS) of patients have demonstrated that MPTM1 is upregulated during heart failure. Additionally, MPTM1 expression strongly increases during skeletal muscle differentiation and maturation. In the present study, we assessed the hypothesis that MPTM1 promotes heart and skeletal muscle homeostasis using both in vitro and in vivo gain- and loss-of-function approaches. Furthermore, we generated C2C12 myoblast and NIH3T3 fibroblast cell lines null for MPTM1 using CRISPR/Cas9 gene editing methods. MPTM1 depletion in knockout cell lines resulted in striking membrane and nuclear abnormalities. Additionally, MPTM1 null C2C12 cells exhibited defects in myoblast differentiation characterized by premature myosin expression, altered cellular architecture, abnormal nuclear distribution, and the accumulation of intracellular vacuoles. We further evaluated MPTM1 cellular function using CRISPR/Cas9 homology-directed repair (HDR) to insert tandem affinity tags (3XHA-V5 or 3X FLAG) into the MPTM1 locus to assess binding partners in vitro using immunoprecipitation and mass spectrometry. Our results provide strong evidence that MPTM1 is a multi-localizing protein that is differentially recruited to the cytosol, nucleolus, and mitochondria, indicating it may act as a key intracellular signaling effector in response to stress. Additional studies in MPTM1 null mice are ongoing and will provide critical insight into MPTM1 function in the heart at under normal physiologic conditions and in response to pathological stress.
    Type of Medium: Online Resource
    ISSN: 0009-7330 , 1524-4571
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2022
    detail.hit.zdb_id: 1467838-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    In: Circulation Research, Ovid Technologies (Wolters Kluwer Health), Vol. 112, No. 3 ( 2013-02), p. 498-509
    Abstract: In the failing heart, persistent β-adrenergic receptor activation is thought to induce myocyte death by protein kinase A (PKA)-dependent and PKA-independent activation of calcium/calmodulin-dependent kinase II. β-adrenergic signaling pathways also are capable of activating cardioprotective mechanisms. Objective: This study used a novel PKA inhibitor peptide to inhibit PKA activity to test the hypothesis that β-adrenergic receptor signaling causes cell death through PKA-dependent pathways and cardioprotection through PKA-independent pathways. Methods and Results: In PKA inhibitor peptide transgenic mice, chronic isoproterenol failed to induce cardiac hypertrophy, fibrosis, and myocyte apoptosis, and decreased cardiac function. In cultured adult feline ventricular myocytes, PKA inhibition protected myocytes from death induced by β1-adrenergic receptor agonists by preventing cytosolic and sarcoplasmic reticulum Ca 2+ overload and calcium/calmodulin-dependent kinase II activation. PKA inhibition revealed a cardioprotective role of β-adrenergic signaling via cAMP/exchange protein directly activated by cAMP/Rap1/Rac/extracellular signal-regulated kinase pathway. Selective PKA inhibition causes protection in the heart after myocardial infarction that was superior to β-blocker therapy. Conclusions: These results suggest that selective block of PKA could be a novel heart failure therapy.
    Type of Medium: Online Resource
    ISSN: 0009-7330 , 1524-4571
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2013
    detail.hit.zdb_id: 1467838-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    MyJove Corporation ; 2022
    In:  Journal of Visualized Experiments , No. 185 ( 2022-07-12)
    In: Journal of Visualized Experiments, MyJove Corporation, , No. 185 ( 2022-07-12)
    Type of Medium: Online Resource
    ISSN: 1940-087X
    Language: English
    Publisher: MyJove Corporation
    Publication Date: 2022
    detail.hit.zdb_id: 2259946-0
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    In: Circulation, Ovid Technologies (Wolters Kluwer Health), Vol. 142, No. Suppl_3 ( 2020-11-17)
    Abstract: Introduction: Emerging evidence suggests that many RNA molecules currently annotated as noncoding contain short open reading frames that code for functional small proteins called microproteins. Microproteins play critical roles in a diverse range of essential biological processes. To identify novel cardiac-expressed microproteins, we used a comparative genomics approach and identified mitolamban (Mtlbn) as a highly conserved 47-amino acid transmembrane protein that is abundantly expressed in the heart. Methods and Results: Subcellular localization studies showed that Mtlbn localized specifically to the inner mitochondrial membrane. Immunoprecipitations and mass spectrometry analysis indicated that Mtlbn interacted with subunits of complex III of the electron transport chain (ETC) and we observed the presence of Mtlbn in complex III respiratory supercomplexes (SCs) by blue native polyacrylamide gel electrophoresis (BN-PAGE). Cardiac-specific Mtlbn overexpressing transgenic (TG) mice and Mtlbn gene-deleted (knockout, KO) mice were generated to dissect the molecular function of this protein in the heart. Mtlbn TG mice developed cardiomyopathy and died prematurely with histological, biochemical and ultrastructural pathologic features. Metabolomic analysis indicated that hearts from TG mice had signs of increased oxidative stress and mitochondrial dysfunction. While Mtlbn KO mice had normal cardiac function and histological appearance, BN-PAGE analysis of purified mitochondria from KO hearts showed altered complex III composition. Functional assessment of purified heart mitochondria from Mtlbn KO mice revealed a reduction in complex III activity and metabolomic analysis of KO heart tissue indicated an altered metabolite profile consistent with deficiencies in complex III activity. Conclusions: Mtlbn is a novel heart-enriched microprotein that localizes to the inner mitochondrial membrane where it interacts with complex III of the ETC. Our data indicate that Mtlbn serves as a critical regulator of mitochondrial ETC activity through a direct role in affecting complex III function.
    Type of Medium: Online Resource
    ISSN: 0009-7322 , 1524-4539
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2020
    detail.hit.zdb_id: 1466401-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    In: Circulation Research, Ovid Technologies (Wolters Kluwer Health), Vol. 117, No. suppl_1 ( 2015-07-17)
    Abstract: Background: Mammalian transcriptomes contain thousands of potential open reading frames (ORFs) with fewer than fifty codons. Most of these ORFs are presumed to be random and therefore noncoding, but recently several genes annotated as long noncoding RNAs (lncRNAs) were shown to encode functional micropeptides. Objective: Identify and characterize novel micropeptides encoded in cardiac-expressed lncRNAs using comparative genomics. Methods and Results: Using codon substitution frequency, a comparative genomics strategy, we identified several previously unknown small proteins, including a 34-amino acid micropeptide that we have named DWORF ( Dw arf O pen R eading F rame). DWORF is a tail-anchored transmembrane protein that localizes to the sarcoplasmic reticulum and is expressed only in cardiac ventricle and slow-twitch skeletal muscle by quantitative PCR. We subsequently derived a custom antibody targeting the N-terminal residues of DWORF. Western blots using this antibody revealed a 4 kDa protein that is expressed in cardiac ventricle and soleus muscle, but not other tissues. We further validated specificity of this signal by disrupting the reading frame of DWORF in mice using CRISPR/Cas9 mutagenesis, conclusively demonstrating that the mRNA encodes a small protein. Transgenic overexpression of DWORF in cardiac myocytes resulted in increased peak amplitude of Ca 2+ transients and improved Ca 2+ resequestration kinetics with no apparent adverse effects. These findings suggest that DWORF specifically enhances activity of the sarco/endoplasmic reticulum calcium ATPase (SERCA). Conclusions: Some putative lncRNAs encode micropeptides that can be identified using bioinformatics strategies. Micropeptides, though likely too small to have enzymatic activity of their own, may have modulatory functions in important cellular processes such as calcium handling, as we have demonstrated in the case of the muscle-restricted micropeptide DWORF.
    Type of Medium: Online Resource
    ISSN: 0009-7330 , 1524-4571
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2015
    detail.hit.zdb_id: 1467838-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    In: Circulation Research, Ovid Technologies (Wolters Kluwer Health), Vol. 117, No. suppl_1 ( 2015-07-17)
    Abstract: Functional micropeptides can be concealed within RNA transcripts that have been putatively annotated as non-coding. We recently discovered a muscle-specific micropeptide, named myoregulin (MLN), that inhibits the activity of SERCA, the membrane pump that controls muscle relaxation by regulating Ca2+ uptake into the sarcoplasmic reticulum (SR). Genetic deletion of MLN in mice enhances Ca2+ handling in skeletal muscle and improves exercise performance. MLN shares structural and functional similarity with phospholamban (PLN) and sarcolipin (SLN), two well-studied micropeptides that regulate cardiac contractility and disease. Here we identify an additional member of this micropeptide family, named endoregulin (ELN), that specifically overlaps with the expression of SERCA3, the dominant Ca2+ ATPase in endothelial cells that controls the contractility of vascular and visceral smooth muscles. ELN encodes a single transmembrane alpha helix that localizes to the endoplasmic reticulum (ER), where it forms a stable complex with SERCA3. In cell based assays, ELN inhibits SERCA-dependent Ca2+ uptake into the ER and controls ER calcium levels. Due to the essential role of SERCA3 in regulating vascular smooth muscle contractility, ELN represents a potential regulator of vascular tone and novel therapeutic target for the treatment of cardiovascular disease.
    Type of Medium: Online Resource
    ISSN: 0009-7330 , 1524-4571
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2015
    detail.hit.zdb_id: 1467838-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    Ovid Technologies (Wolters Kluwer Health) ; 2013
    In:  Circulation Research Vol. 113, No. suppl_1 ( 2013-08)
    In: Circulation Research, Ovid Technologies (Wolters Kluwer Health), Vol. 113, No. suppl_1 ( 2013-08)
    Abstract: Background— Ca 2+ influx through L-type Ca 2+ channels (LTCCs) induces Ca 2+ release from the SR to induce and regulate cardiac contraction. We have characterized a mouse model with cardiac-specific expression of the β2a subunit of the LTCC (β2a), leading to pathological hypertrophy due to excessive LTCC Ca 2+ entry. Chronic exercise causes physiological hypertrophy in normal hearts. We determined if swim training improved or further deranged the performance of β2a mice. Methods and Results— β2a (n=12) and WT (n=20) mice were swim trained for 21 consecutive days. ECHO was performed at beginning and end of swim training. Ejection fraction (EF) and fractional shortening (FS) increased significantly with swim training in WT animals. (EF pre-swim: 57±2.02% vs. post-swim: 70±2.88%; FS pre-swim: 30±1.34% vs. post-swim: 39±2.42%). β2a mice were hypercontractile before swimming and had no significant change after training (EF pre-swim: 70±1.75% vs. post-swim: 74.06±2.72%; FS pre-training: 38±2.38% vs. post-training: 42±2.22%). Contractile performance was significantly greater in β2a mice versus WT before but not after training. There was a significant increase in HW/BW [mg/gm] ratio in trained WT (n=8) versus sedentary WT (n=8) (swim: 5.75±0.19 vs. sed: 4.63±0.2) but training did not cause additional hypertrophy in β2a (n=8) versus sedentary (n=7) (swim: 5.98±0.31 vs. sed: 5.96±0.25). Isolated WT and β2a hearts were placed on a Langendorff apparatus and a balloon was inserted into the LV to record isovolumic pressure. Each heart underwent 15 min of ischemia followed by 30 min of reperfusion. End diastolic pressure (EDP) increased in all hearts during ischemia. There were no protective effects of training on ischemia-induced increases in EDP in WT hearts. EDP increased more in sedentary β2a during ischemia but this effect was eliminated in trained β2a hearts. LV developed pressure (LVDP) fell with ischemia and partially recovered with reperfusion. LVDP recovery was significantly greater in trained versus sedentary WT hearts. Swim training also significantly improved LVDP recovery in β2a hearts. Conclusions— Chronic exercise training reduces pathological hypertrophy and damaging effects of ischemia in a murine model of LTCC overexpression.
    Type of Medium: Online Resource
    ISSN: 0009-7330 , 1524-4571
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2013
    detail.hit.zdb_id: 1467838-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    Online Resource
    Online Resource
    Portland Press Ltd. ; 2007
    In:  Biochemical Journal Vol. 405, No. 2 ( 2007-07-15), p. 233-241
    In: Biochemical Journal, Portland Press Ltd., Vol. 405, No. 2 ( 2007-07-15), p. 233-241
    Abstract: GRP94 (glucose-regulated protein of 94 kDa) is a major luminal constituent of the endoplasmic reticulum with known high capacity for calcium in vivo and a peptide-binding activity in vitro. In the present study, we show that Ca2+ regulates the ability of GRP94 to bind peptides. This effect is due to a Ca2+-binding site located in the charged linker domain of GRP94, which, when occupied, enhances the association of peptides with the peptide-binding site in the N-terminal domain of the protein. We further show that grp94−/− cells are hypersensitive to perturbation of intracellular calcium and thus GRP94 is important for cellular Ca2+ storage.
    Type of Medium: Online Resource
    ISSN: 0264-6021 , 1470-8728
    RVK:
    Language: English
    Publisher: Portland Press Ltd.
    Publication Date: 2007
    detail.hit.zdb_id: 1473095-9
    SSG: 12
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    In: Journal of the American Heart Association, Ovid Technologies (Wolters Kluwer Health), Vol. 12, No. 3 ( 2023-02-07)
    Abstract: Cardiomyopathy is a leading health threat in Duchenne muscular dystrophy (DMD). Cytosolic calcium upregulation is implicated in DMD cardiomyopathy. Calcium is primarily removed from the cytosol by the sarcoendoplasmic reticulum calcium ATPase (SERCA). SERCA activity is reduced in DMD. Improving SERCA function may treat DMD cardiomyopathy. Dwarf open reading frame (DWORF) is a recently discovered positive regulator for SERCA, hence, a potential therapeutic target. Methods and Results To study DWORF's involvement in DMD cardiomyopathy, we quantified DWORF expression in the heart of wild‐type mice and the mdx model of DMD. To test DWORF gene therapy, we engineered and characterized an adeno‐associated virus serotype 9–DWORF vector. To determine if this vector can mitigate DMD cardiomyopathy, we delivered it to 6‐week‐old mdx mice (6×10 12 vector genome particles/mouse) via the tail vein. Exercise capacity, heart histology, and cardiac function were examined at 18 months of age. We found DWORF expression was significantly reduced at the transcript and protein levels in mdx mice. Adeno‐associated virus serotype 9–DWORF vector significantly enhanced SERCA activity. Systemic adeno‐associated virus serotype 9‐DWORF therapy reduced myocardial fibrosis and improved treadmill running, electrocardiography, and heart hemodynamics. Conclusions Our data suggest that DWORF deficiency contributes to SERCA dysfunction in mdx mice and that DWORF gene therapy holds promise to treat DMD cardiomyopathy.
    Type of Medium: Online Resource
    ISSN: 2047-9980
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2023
    detail.hit.zdb_id: 2653953-6
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages